The University of Missouri Research Reactor next year plans to file a license application with the Nuclear Regulatory Commission to produce molybdenum 99 -- the source isotope of technetium 99m used in nuclear medicine. The research reactor is aiming to supply about 50% of the country's demand for "moly 99" using low-enriched uranium within the next four years.

Related Summaries